Anti-diabetic effects of resveratrol
- PMID: 21261639
- DOI: 10.1111/j.1749-6632.2010.05844.x
Anti-diabetic effects of resveratrol
Abstract
Diabetes mellitus is a complex metabolic disease affecting about 5% of people all over the world. Data from the literature indicate that resveratrol is a compound exerting numerous beneficial effects in organisms. Rodent studies, for example, have demonstrated that resveratrol decreases blood glucose in animals with hyperglycemia. This effect seems to predominantly result from increased intracellular transport of glucose. Resveratrol was also demonstrated to induce effects that may contribute to the protection of β cells in diabetes. In experiments on pancreatic islets, the ability of resveratrol to reduce insulin secretion was demonstrated; this effect was confirmed in animals with hyperinsulinemia, in which resveratrol decreased blood insulin levels. Moreover, inhibition of cytokine action and attenuation of the oxidative damage of the pancreatic tissue by resveratrol were recently shown. Studies of animals with insulin resistance indicate that resveratrol may also improve insulin action. The mechanism through which resveratrol improves insulin action is complex and involves reduced adiposity, changes in gene expression, and changes in the activities of some enzymes. These data indicate that resveratrol may be useful in preventing and treating diabetes.
© 2011 New York Academy of Sciences.
Similar articles
-
Resveratrol and diabetes: from animal to human studies.Biochim Biophys Acta. 2015 Jun;1852(6):1145-54. doi: 10.1016/j.bbadis.2014.10.013. Epub 2014 Oct 27. Biochim Biophys Acta. 2015. PMID: 25445538 Review.
-
Protection of pancreatic beta-cells: is it feasible?Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. doi: 10.1016/j.numecd.2007.05.004. Nutr Metab Cardiovasc Dis. 2008. PMID: 18096375 Review.
-
Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats.J Cell Physiol. 2010 Aug;224(2):423-32. doi: 10.1002/jcp.22138. J Cell Physiol. 2010. PMID: 20333650
-
Resveratrol and diabetes: A critical review of clinical studies.Biomed Pharmacother. 2017 Nov;95:230-234. doi: 10.1016/j.biopha.2017.08.070. Epub 2017 Sep 12. Biomed Pharmacother. 2017. PMID: 28843911 Review.
-
Resveratrol, obesity and diabetes.Eur J Pharmacol. 2010 Jun 10;635(1-3):1-8. doi: 10.1016/j.ejphar.2010.02.054. Epub 2010 Mar 19. Eur J Pharmacol. 2010. PMID: 20303945 Review.
Cited by
-
Resveratrol ameliorates the maturation process of β-cell-like cells obtained from an optimized differentiation protocol of human embryonic stem cells.PLoS One. 2015 Mar 16;10(3):e0119904. doi: 10.1371/journal.pone.0119904. eCollection 2015. PLoS One. 2015. PMID: 25774684 Free PMC article.
-
Drug Discovery of Plausible Lead Natural Compounds That _target the Insulin Signaling Pathway: Bioinformatics Approaches.Evid Based Complement Alternat Med. 2022 Mar 20;2022:2832889. doi: 10.1155/2022/2832889. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35356248 Free PMC article. Review.
-
The Action of Polyphenols in Diabetes Mellitus and Alzheimer's Disease: A Common Agent for Overlapping Pathologies.Curr Neuropharmacol. 2019;17(7):590-613. doi: 10.2174/1570159X16666180803162059. Curr Neuropharmacol. 2019. PMID: 30081787 Free PMC article.
-
Resveratrol induces insulin gene expression in mouse pancreatic α-cells.Cell Biosci. 2013 Dec 13;3(1):47. doi: 10.1186/2045-3701-3-47. Cell Biosci. 2013. PMID: 24330680 Free PMC article.
-
Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD.Front Pharmacol. 2022 Aug 9;13:896899. doi: 10.3389/fphar.2022.896899. eCollection 2022. Front Pharmacol. 2022. PMID: 36016562 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
